Shandong Hualu-Hengsheng Chemical (600426) H1 2025 earnings summary

Executive summary

• Revenue for the first half of 2025 was ¥15.76 billion, down 7.14% year-over-year due to product price declines despite higher sales volume.

• Net profit attributable to shareholders was ¥1.57 billion, a 29.47% decrease year-over-year, mainly from lower product prices and increased competition.

• The company maintained high market share in core products and continued to lead in industry positioning.

• Major projects such as the amide raw material upgrade and 200,000-ton/year dibasic acid project neared completion, supporting future growth.

Financial highlights

• Operating income: ¥15.76 billion, down 7.14% year-over-year.

• Net profit attributable to shareholders: ¥1.57 billion, down 29.47% year-over-year.

• Operating cash flow: ¥2.33 billion, down 19.84% year-over-year.

• Total assets: ¥48.28 billion, up 3.48% from year-end 2024.

• Basic and diluted EPS: ¥0.739, down 29.48% year-over-year.

• Gross margin: 17.9% (calculated from disclosed data).

Outlook and guidance

• The company plans to distribute a cash dividend of ¥2.50 (pre-tax) per 10 shares for the half-year, with no bonus shares or capital increase.

• Management expects continued industry pressure from overcapacity and raw material price volatility, but will focus on technology upgrades, cost control, and market expansion.